ASTROTECH Corp Net Income (Loss) Available to Common Stockholders, Diluted
ASTROTECH Corp (ASTC) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$4.96 million for the 12-month period ending 2014-06-30, per its 10-K filed 2014-09-30.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2014-09-30
- ASTROTECH Corp net income (loss) available to common stockholders, diluted for the quarter ending 2012-12-31 was $0.00.
- ASTROTECH Corp net income (loss) available to common stockholders, diluted for the quarter ending 2012-09-30 was $0.00.
- ASTROTECH Corp net income (loss) available to common stockholders, diluted for the quarter ending 2011-12-31 was $0.00.
- ASTROTECH Corp net income (loss) available to common stockholders, diluted for the quarter ending 2011-09-30 was $0.00.
- ASTROTECH Corp net income (loss) available to common stockholders, diluted for fiscal 2014 was -$4.96M.
- ASTROTECH Corp net income (loss) available to common stockholders, diluted for fiscal 2013 was -$185.00K.
- ASTROTECH Corp net income (loss) available to common stockholders, diluted for fiscal 2012 was -$2.71M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month |
|---|---|---|---|
| 2014-06-30 | -$4.96M 10-K · filed 2014-09-30 | ||
| 2013-06-30 | -$185.00K 10-K · filed 2014-09-30 | ||
| 2012-12-31 | $0.00 10-Q · filed 2013-02-14 | $0.00 10-Q · filed 2013-02-14 | |
| 2012-09-30 | $0.00 10-Q · filed 2012-11-14 | ||
| 2012-06-30 | -$2.71M 10-K · filed 2013-10-15 | ||
| 2011-12-31 | $0.00 10-Q · filed 2013-02-14 | $0.00 10-Q · filed 2013-02-14 | |
| 2011-09-30 | $0.00 10-Q · filed 2012-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |